Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Patterns of care for the treatment of bladder cancer.

Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R.

J Urol. 2003 May;169(5):1697-701.

PMID:
12686811
2.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association.

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

3.
4.

Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study.

Prout GR Jr, Wesley MN, Yancik R, Ries LA, Havlik RJ, Edwards BK.

Cancer. 2005 Oct 15;104(8):1638-47.

5.

The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.

Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.

BJU Int. 2004 Dec;94(9):1258-62.

7.

Adherence to surveillance among patients with superficial bladder cancer.

Schrag D, Hsieh LJ, Rabbani F, Bach PB, Herr H, Begg CB.

J Natl Cancer Inst. 2003 Apr 16;95(8):588-97.

PMID:
12697851
8.

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.

Schrag D, Mitra N, Xu F, Rabbani F, Bach PB, Herr H, Begg CB.

Urology. 2005 Jun;65(6):1118-25.

PMID:
15922428
9.

Conservative management of low risk superficial bladder tumors.

Pruthi RS, Baldwin N, Bhalani V, Wallen EM.

J Urol. 2008 Jan;179(1):87-90; discussion 90. Epub 2007 Nov 12.

PMID:
17997444
10.

A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden.

Jahnson S, Damm O, Hellsten S, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Strömberg F, Wijkstöm H.

Scand J Urol Nephrol. 2009;43(4):271-6. doi: 10.1080/00365590902909778.

PMID:
19424934
11.

Understanding bladder cancer death: tumor biology versus physician practice.

Morris DS, Weizer AZ, Ye Z, Dunn RL, Montie JE, Hollenbeck BK.

Cancer. 2009 Mar 1;115(5):1011-20. doi: 10.1002/cncr.24136.

12.

Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.

Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.

Urology. 2004 Mar;63(3):466-71.

PMID:
15028439
13.
14.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
15.

Optimal management of high-risk T1G3 bladder cancer: a decision analysis.

Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM.

PLoS Med. 2007 Sep;4(9):e284.

16.
17.

Carcinoma in a bladder diverticulum: presentation and treatment outcome.

Golijanin D, Yossepowitch O, Beck SD, Sogani P, Dalbagni G.

J Urol. 2003 Nov;170(5):1761-4.

PMID:
14532771
18.

Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.

Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.

Eur Urol. 2005 Jul;48(1):53-9; discussion 59. Epub 2005 Apr 7.

PMID:
15967252
19.

Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation.

Pieras E, Palou J, Salvador J, Rosales A, Marcuello E, Villavicencio H.

Eur Urol. 2003 Aug;44(2):222-5; discussoion 225.

PMID:
12875942
20.

Bladder and upper tract urothelial cancer.

Konety BR, Joyce GF, Wise M.

J Urol. 2007 May;177(5):1636-45.

PMID:
17437776

Supplemental Content

Support Center